Shan Lin
Ophthalmology · San Francisco, CANPI 1730131236
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $227,058 of the $374,003 with a category attached, or 60.7%. 21 manufacturers reported payments, led by Iridex Corporation at 40.0% of the total. Reporting peaked in 2019 at $106,495 and has fallen 88.1% since, to $12,662 in 2025. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $1242.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Iridex Corporation$150K
- Aerie Pharmaceuticals, Inc.$129K
- Alcon$38K
- Bausch & Lomb Americas Inc.$28K
- AbbVie$13K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$10K
- plus $5K from 15 others
What the payments were for
- Consulting fees$227,05861%
- Speaking & faculty fees$116,73331%
- Travel & lodging$19,7335%
- Food & beverage$9,9793%
- Other$5010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Iridex Corporation | 29 | $149,525 |
| Aerie Pharmaceuticals, Inc. | 71 | $129,278 |
| Alcon | 64 | $38,272 |
| Bausch & Lomb Americas Inc. | 39 | $28,187 |
| AbbVie(2 entities) | 25 | $13,485 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 22 | $10,102 |
| Dompe US, Inc. | 3 | $2,379 |
| NEW World Medical,inc. | 8 | $865 |
| Carl Zeiss Meditec USA, Inc. | 2 | $526 |
| Sight Sciences, Inc. | 14 | $461 |
| Thea Pharma Inc. | 8 | $235 |
| Beaver-visitec International, Inc. | 2 | $224 |
| Novartis | 4 | $109 |
| Oyster Point Pharma, Inc. | 1 | $98 |
| Glaukos Corporation | 1 | $71 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| Ivantis, Inc | 2 | $41 |
| Rayner Intraocular Lenses Limited | 1 | $34 |
| Amgen | 1 | $29 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rocklatan$132,868
- Rhopressa$123,182
- VYZULTA$36,870
- Oxervate$2,275
- Kahook Dual Blade$654
- Clearpath$654
- Ahmed Glaucoma Valve$654
- Streamline$654
- Hydrus Microstent$556
- LUMERA$501
- Via360$155
- XEN$150
- DOCTORS ALLERGY FORMULA$108
- LUMIGAN$104
- OMNI(R) SURGICAL SYSTEM (US)$100
How this compares
$374,003 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in San Francisco
- Daniel SchwartzSan Francisco$8M
- Gaurav ShahSan Francisco$620K
- H TanakaSan Francisco$238K
- Jay StewartSan Francisco$219K
- Scott SoSan Francisco$173K
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.